HSV shedding

被引:69
作者
Sacks, SL
Griffiths, PD
Corey, L
Cohen, C
Cunningham, A
Dusheiko, GM
Self, S
Spruance, S
Stanberry, LR
Wald, A
Whitley, RJ
机构
[1] Univ Alabama, Birmingham, AL 35233 USA
[2] Viridae, Vancouver, BC, Canada
[3] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London, England
[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Westmead Millennium Inst, Westmead, NSW, Australia
[7] UCL Royal Free Hosp, Acad Dept Med, London NW3 2QG, England
[8] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA
[9] Univ Texas, Med Branch, Dept Pediat, Galveston, TX 77550 USA
[10] Univ Texas, Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77550 USA
[11] Univ Washington, Seattle, WA 98195 USA
关键词
HSV; shedding; transmission; PCR; antiviral;
D O I
10.1016/j.antiviral.2004.06.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Viral shedding of HSV occurs frequently in infected individuals. HSV is shed asymptomatically from multiple anatomical sites and shedding, like exposure, is a significant risk for transmission. However, the relationship between shedding frequency, viral titer and transmission is unknown. HSV-2 shedding is affected by the site and time since acquisition of infection. The advent of sensitive PCR techniques has shown that the magnitude and frequency of viral shedding is higher than shown previously with viral culture techniques. It has also clearly demonstrated that suppressive (daily) antiviral therapy reduces clinical and subelinical reactivation rates, and has been successfully used in the prevention of recurrent oral and genital HSV infections. A recent study has demonstrated that daily antiviral therapy with valaciclovir can significantly reduce transmission of HSV-2 between discordant heterosexual couples in monogamous relationships. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:S19 / S26
页数:8
相关论文
共 27 条
[11]  
RATTRAY MC, 1978, BRIT J VENER DIS, V54, P262
[12]   ORAL ACYCLOVIR TO SUPPRESS FREQUENTLY RECURRENT HERPES LABIALIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
ROONEY, JF ;
STRAUS, SE ;
MANNIX, ML ;
WOHLENBERG, CR ;
ALLING, DW ;
DUMOIS, JA ;
NOTKINS, AL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (04) :268-272
[13]   Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: A randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial [J].
Sacks, SL .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (08) :1341-1347
[14]   The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia [J].
Sawtell, NM .
JOURNAL OF VIROLOGY, 1998, 72 (08) :6888-6892
[15]   Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons - A double-blind, placebo-controlled trial [J].
Schacker, T ;
Hu, HL ;
Koelle, DM ;
Zeh, J ;
Saltzman, R ;
Boon, R ;
Shaughnessy, M ;
Barnum, G ;
Corey, L .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) :21-+
[16]   Elimination of duck hepatitis B virus RNA-containing capsids in duck interferon-alpha-treated hepatocytes [J].
Schultz, U ;
Summers, J ;
Staeheli, P ;
Chisari, FV .
JOURNAL OF VIROLOGY, 1999, 73 (07) :5459-5465
[17]   ACYCLOVIR PREVENTS REACTIVATION OF HERPES-SIMPLEX LABIALIS IN SKIERS [J].
SPRUANCE, SL ;
HAMILL, ML ;
HOGE, WS ;
DAVIS, LG ;
MILLS, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (11) :1597-1599
[18]   PATHOGENESIS OF HERPES-SIMPLEX LABIALIS - EXCRETION OF VIRUS IN THE ORAL CAVITY [J].
SPRUANCE, SL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1984, 19 (05) :675-679
[19]   Glycoprotein-D-adjuvant vaccine to prevent genital herpes [J].
Stanberry, LR ;
Spruance, SL ;
Cunningham, AL ;
Bernstein, DI ;
Mindel, A ;
Sacks, S ;
Tyring, S ;
Aoki, FY ;
Slaoui, M ;
Denis, M ;
Vandepapeliere, P ;
Dubin, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1652-1661
[20]   Prospects for control of herpes simplex virus disease through immunization [J].
Stanberry, LR ;
Cunningham, AL ;
Mindel, A ;
Scott, LL ;
Spruance, SL ;
Aoki, FY ;
Lacey, CJ .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :549-566